Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators.
about
Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and InterventionsMaintaining brain health by monitoring inflammatory processes: a mechanism to promote successful agingRegulation of RAGE splicing by hnRNP A1 and Tra2β-1 and its potential role in AD pathogenesisMetabolic stress modulates Alzheimer's β-secretase gene transcription via SIRT1-PPARγ-PGC-1 in neurons.Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?Targets for AD treatment: conflicting messages from γ-secretase inhibitorsCognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study.Induction of an inflammatory loop by interleukin-1β and tumor necrosis factor-α involves NF-kB and STAT-1 in differentiated human neuroprogenitor cells.A novel mouse model of Alzheimer's disease with chronic estrogen deficiency leads to glial cell activation and hypertrophy.Combined treatment of Aβ immunization with statin in a mouse model of Alzheimer's disease.Coronary risk correlates with cerebral amyloid depositionCan infections cause Alzheimer's disease?The occurrence of cerebrovascular atherosclerosis in Alzheimer's disease patientsSystematic Analysis of Long Noncoding RNAs in the Senescence-accelerated Mouse Prone 8 Brain Using RNA Sequencing.The "aged garlic extract:" (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD).Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficitsAnalyses of mRNA Profiling through RNA Sequencing on a SAMP8 Mouse Model in Response to Ginsenoside Rg1 and Rb1 Treatment.AMP-activated protein kinase: a potential player in Alzheimer's disease.Increased tau phosphorylation and impaired brain insulin/IGF signaling in mice fed a high fat/high cholesterol diet.Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
P2860
Q26781557-2D6B9A77-B556-46AF-BCFD-27776134579DQ28730725-03CD68E5-1FBA-4013-9655-EA2FBF326F3CQ28910474-F6366474-C596-4E28-B93D-09C7F8D5DEA7Q33579072-E56D08BA-84EF-41D8-9406-EB561302DDA3Q34669518-22DAA630-5CC2-4984-8A97-217A270237C9Q34792043-FFD7F8EC-B540-4210-AE94-7E86AD99AFE4Q34802779-92F16554-CB23-4764-A81A-BF3BB327643AQ34903095-87456C2A-7637-4C0F-A724-FABB3AE87E14Q35238318-7E808552-8AD4-434C-ACC2-4DFA55AACF14Q35818921-A88BD854-CFAD-4F24-A5D2-DEF96DDC6460Q36020536-6FA0783B-2581-4363-90D9-0C7C4B155F14Q36449877-28A3824B-0CBB-4F8B-B2AE-47D95308B5A5Q36957279-0504D517-EB70-461A-80AB-430FE92BFD6FQ37256200-2070738C-380E-46D3-9FE5-30E91616A339Q37615989-38B815A6-1258-49B4-B3DA-22503BCE57C2Q37615991-524EBBCA-E6BE-43BC-A724-A60808757C09Q37667260-2BABC032-DCA8-4FA1-B70B-384B7D40F2B1Q37881988-0E17291F-98FB-4CA2-B13D-8A2072D9D47BQ41170006-5D6C1237-5959-46AE-9255-CE57D639B1F3Q50595857-9885B53E-1549-4A4E-A120-5B305E6DEF7A
P2860
Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Linking cardiometabolic disord ...... tial mechanisms and mediators.
@ast
Linking cardiometabolic disord ...... tial mechanisms and mediators.
@en
Linking cardiometabolic disord ...... tial mechanisms and mediators.
@nl
type
label
Linking cardiometabolic disord ...... tial mechanisms and mediators.
@ast
Linking cardiometabolic disord ...... tial mechanisms and mediators.
@en
Linking cardiometabolic disord ...... tial mechanisms and mediators.
@nl
prefLabel
Linking cardiometabolic disord ...... tial mechanisms and mediators.
@ast
Linking cardiometabolic disord ...... tial mechanisms and mediators.
@en
Linking cardiometabolic disord ...... tial mechanisms and mediators.
@nl
P2860
P1476
Linking cardiometabolic disord ...... tial mechanisms and mediators.
@en
P2093
Narayan R Bhat
P2860
P304
P356
10.1111/J.1471-4159.2010.06978.X
P407
P577
2010-09-28T00:00:00Z